0001104659-16-163806.txt : 20161223
0001104659-16-163806.hdr.sgml : 20161223
20161223180340
ACCESSION NUMBER: 0001104659-16-163806
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20161024
FILED AS OF DATE: 20161223
DATE AS OF CHANGE: 20161223
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CRISPR Therapeutics AG
CENTRAL INDEX KEY: 0001674416
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 473173478
STATE OF INCORPORATION: V8
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: AESCHENVORSTADT 36
CITY: BASEL
STATE: V8
ZIP: 4051
BUSINESS PHONE: 6173154600
MAIL ADDRESS:
STREET 1: AESCHENVORSTADT 36
CITY: BASEL
STATE: V8
ZIP: 4051
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Versant Venture Capital V (Canada), LP
CENTRAL INDEX KEY: 0001612235
STATE OF INCORPORATION: A6
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37923
FILM NUMBER: 162069512
BUSINESS ADDRESS:
STREET 1: ONE SANSOME STREET
STREET 2: SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
BUSINESS PHONE: 650-233-7877
MAIL ADDRESS:
STREET 1: ONE SANSOME STREET
STREET 2: SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Versant Ophthalmic Affiliates I, L.P.
CENTRAL INDEX KEY: 0001589098
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37923
FILM NUMBER: 162069513
BUSINESS ADDRESS:
STREET 1: ONE SANSOME STREET
STREET 2: SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
BUSINESS PHONE: 650-233-7877
MAIL ADDRESS:
STREET 1: ONE SANSOME STREET
STREET 2: SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Versant Venture Capital V, L.P.
CENTRAL INDEX KEY: 0001589097
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37923
FILM NUMBER: 162069515
BUSINESS ADDRESS:
STREET 1: ONE SANSOME STREET
STREET 2: SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
BUSINESS PHONE: 650-233-7877
MAIL ADDRESS:
STREET 1: ONE SANSOME STREET
STREET 2: SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Versant Side Fund IV, L.P.
CENTRAL INDEX KEY: 0001456591
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37923
FILM NUMBER: 162069516
BUSINESS ADDRESS:
STREET 1: ONE SANSOME STREET
STREET 2: SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
BUSINESS PHONE: 650-233-2211
MAIL ADDRESS:
STREET 1: ONE SANSOME STREET
STREET 2: SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Versant Venture Capital IV, L.P.
CENTRAL INDEX KEY: 0001456590
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37923
FILM NUMBER: 162069517
BUSINESS ADDRESS:
STREET 1: ONE SANSOME STREET
STREET 2: SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
BUSINESS PHONE: 650-233-2211
MAIL ADDRESS:
STREET 1: ONE SANSOME STREET
STREET 2: SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Versant Affiliates Fund V, L.P.
CENTRAL INDEX KEY: 0001589095
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37923
FILM NUMBER: 162069514
BUSINESS ADDRESS:
STREET 1: ONE SANSOME STREET
STREET 2: SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
BUSINESS PHONE: 650-233-7877
MAIL ADDRESS:
STREET 1: ONE SANSOME STREET
STREET 2: SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
4/A
1
a4a.xml
4/A
X0306
4/A
2016-10-24
2016-10-26
0
0001674416
CRISPR Therapeutics AG
CRSP
0001456590
Versant Venture Capital IV, L.P.
ONE SANSOME STREET, SUITE 3630
SAN FRANCISCO
CA
94104
0
0
1
0
0001456591
Versant Side Fund IV, L.P.
ONE SANSOME STREET, SUITE 3630
SAN FRANCISCO
CA
94104
0
0
1
0
0001589097
Versant Venture Capital V, L.P.
ONE SANSOME STREET, SUITE 3630
SAN FRANCISCO
CA
94104
0
0
1
0
0001589095
Versant Affiliates Fund V, L.P.
ONE SANSOME STREET, SUITE 3630
SAN FRANCISCO
CA
94104
0
0
1
0
0001589098
Versant Ophthalmic Affiliates I, L.P.
ONE SANSOME STREET, SUITE 3630
SAN FRANCISCO
CA
94104
0
0
1
0
0001612235
Versant Venture Capital V (Canada), LP
ONE SANSOME STREET, SUITE 3630
SAN FRANCISCO
CA
94104
0
0
1
0
Common Stock
2016-10-24
4
C
0
437247
A
676895
I
Footnote
Common Stock
2016-10-24
4
C
0
3100477
A
3777372
I
Footnote
Common Stock
2016-10-24
4
C
0
231077
A
4008449
I
Footnote
Common Stock
2016-10-24
4
P
0
95596
14.00
A
4104045
I
Footnote
Common Stock
2016-10-24
4
C
0
2754
A
2754
I
Footnote
Common Stock
2016-10-24
4
C
0
19524
A
22278
I
Footnote
Common Stock
2016-10-24
4
C
0
1454
A
23732
I
Footnote
Common Stock
2016-10-24
4
P
0
602
14.00
A
24334
I
Footnote
Common Stock
2016-10-24
4
C
0
2210417
A
2210417
I
Footnote
Common Stock
2016-10-24
4
C
0
173167
A
2383584
I
Footnote
Common Stock
2016-10-24
4
P
0
60219
14.00
A
2443803
I
Footnote
Common Stock
2016-10-24
4
C
0
66490
A
66490
I
Footnote
Common Stock
2016-10-24
4
C
0
5210
A
71700
I
Footnote
Common Stock
2016-10-24
4
C
0
168224
A
168224
I
Footnote
Common Stock
2016-10-24
4
C
0
13180
A
181404
I
Footnote
Common Stock
2016-10-24
4
P
0
4583
14.00
A
185987
I
Footnote
Common Stock
2016-10-24
4
C
0
73704
A
73704
I
Footnote
Common Stock
2016-10-24
4
C
0
5774
A
79478
I
Footnote
Series A-1 Preferred Shares
2016-10-24
4
C
0
437247
D
Common Stock
437247
0
I
See footnote
Series A-1 Preferred Shares
2016-10-24
4
C
0
2754
D
Common Stock
2754
0
I
See footnote
Series A-2 Preferred Shares
2016-10-24
4
C
0
3100477
D
Common Stock
3100477
0
I
See footnote
Series A-2 Preferred Shares
2016-10-24
4
C
0
19524
D
Common Stock
19524
0
I
See footnote
Series A-3 Preferred Shares
2016-10-24
4
C
0
2210417
D
Common Stock
2210417
0
I
See footnote
Series A-3 Preferred Shares
2016-10-24
4
C
0
66490
D
Common Stock
66490
0
I
See footnote
Series A-3 Preferred Shares
2016-10-24
4
C
0
168224
D
Common Stock
168224
0
I
See footnote
Series A-3 Preferred Shares
2016-10-24
4
C
0
73704
D
Common Stock
73704
0
I
See footnote
Series B Preferred Shares
2016-10-24
4
C
0
231077
D
Common Stock
231077
0
I
See footnote
Series B Preferred Shares
2016-10-24
4
C
0
1454
D
Common Stock
1454
0
I
See footnote
Series B Preferred Shares
2016-10-24
4
C
0
173167
D
Common Stock
173167
0
I
See footnote
Series B Preferred Shares
2016-10-24
4
C
0
5210
D
Common Stock
5210
0
I
See footnote
Series B Preferred Shares
2016-10-24
4
C
0
13180
D
Common Stock
13180
0
I
See footnote
Series B Preferred Shares
2016-10-24
4
C
0
5774
D
Common Stock
5774
0
I
See footnote
Each share of the Issuer's Series A-1 Preferred Stock, Series A-2 Preferred Stock, Series A-3 Preferred Stock and Series B Preferred Stock automatically converted into 1 share of the Issuer's Common Stock in its firm commitment initial public offering pursuant to the Issuer's prospectus (Form 424B4) filed with the Securities and Exchange Commission on October 19, 2016.
These securities are held of record by Versant Venture Capital IV, L.P. ("VVC IV"). Versant Ventures IV, LLC ("VV IV") is the sole general partner of VVC IV and may be deemed to have voting and investment power over the securities held by VVC IV and as a result may be deemed to have beneficial ownership over such securities, however, VV IV disclaims beneficial ownership of the securities held by VVC IV, except to the extent of its pecuniary interests therein.
These securities are held of record by Versant Side Fund IV, L.P. ("VSF IV"). VV IV is the sole general partner of VSF IV and may be deemed to have voting and investment power over the securities held by VSF IV and as a result may be deemed to have beneficial ownership over such securities, however, VV IV disclaims beneficial ownership of the securities held by VSF IV, except to the extent of its pecuniary interests therein.
These securities are held of record by Versant Venture Capital V, L.P. ("VVC V"). Versant Ventures V, LLC ("VV V") is the sole general partner of VVC V and may be deemed to have voting and investment power over the securities held by VVC V and as a result may be deemed to have beneficial ownership over such securities, however, VV V disclaims beneficial ownership of the securities held by VVC V, except to the extent of its pecuniary interests therein.
These securities are held of record by Versant Affiliates Fund V, L.P. ("VAF V"). VV V is the sole general partner of VAF V and may be deemed to have voting and investment power over the securities held by VAF V and as a result may be deemed to have beneficial ownership over such securities, however, VV V disclaims beneficial ownership of the securities held by VAF V, except to the extent of its pecuniary interests therein.
These securities are held of record by Versant Venture Capital V (Canada) LP ("VVC CAN"). Versant Ventures V (Canada) GP-GP, Inc. ("VV V CAN GP") is the sole general partner of Versant Ventures V (Canada), L.P. ("VV V CAN") and VV V CAN is the sole general partner of VVC CAN. VV V CAN GP and VV V CAN may be deemed to have voting and investment power over the securities held by VVC CAN and as a result may be deemed to have beneficial ownership over such securities, however, each disclaim beneficial ownership of the securities held by VVC CAN, except to the extent of their pecuniary interests therein.
These securities are held of record by Versant Ophthalmic Affiliates Fund I, L.P. ("VOA"). VV V is the sole general partner of VOA and may be deemed to have voting and investment power over the securities held by VOA and as a result may be deemed to have beneficial ownership over such securities, however, VV V disclaims beneficial ownership of the securities held by VOA, except to the extent of its pecuniary interests therein.
This amendment is being filed solely to report the conversion of preferred stock into common stock that occurred upon the closing of the Issuer's initial public offering (the "IPO") on October 24, 2016, which conversion was inadvertently omitted from the original Form 4 filed on October 26, 2016, and to correct the transaction code for the purchases in the IPO, which was previously reported as "A," and not to report any other transactions in securities of the Issuer.
Versant Venture Capital IV, L.P. By: Versant Ventures IV, LLC By: Name: Robin L. Praeger Title: Managing Director
2016-12-23
Versant Side Fund IV, L.P. By: Versant Ventures IV, LLC By: Name: Robin L. Praeger Title: Managing Director
2016-12-23
Versant Venture Capital V, L.P. By: Versant Ventures V, LLC By: Name: Robin L. Praeger Title: Managing Director
2016-12-23
Versant Affiliates Fund V, L.P. By: Versant Ventures V, LLC By: Name: Robin L. Praeger Title: Managing Director
2016-12-23
Versant Ophthalmic Affiliates Fund I, L.P. By: Versant Ventures V, LLC By: Name: Robin L. Praeger Title: Managing Director
2016-12-23
Versant Venture Capital V (Canada) LP By: Versant Ventures V (Canada), L.P. By: Versant Ventures V GP-GP, Inc. By: Name: Robin L. Praeger Title: Director
2016-12-23